Xiaojin Liu

Scientist Ascidian Therapeutics

Seminars

Thursday 3rd December 2026
Roundtable discussion: Improving Assay Transferability Through Stronger QC & Analytical Development Alignment
1:45 pm
  • Establishing early-stage QC criteria that support downstream development and IND readiness
  • Aligning assay design, SOP development, and analytical requirements across teams
  • Reducing variability by improving AAV quality standards, supplier oversight, and method transferability
Xiaojin Liu